Skip to main content

Table 1 Subject characteristics

From: The 50% and 95% effective dose of remimazolam tosilate for anaesthesia induction in sleep disorders patients undergoing laparoscopic cholecystectomy: an up-and-down sequential allocation trial

Characteristic

Patients, No.(%)

Sleep disorders (n = 27)

Non-sleep disorders (n = 29)

P

Sex (male/female)

11/16

10/19

0.863

Age (median, y)

47.1 ± 9.4

49.5 ± 6.8

0.086

BMI (median, kg/m2)

24.3 ± 2.1

25.4 ± 2.0

0.899

PSQI scores

8.19 ± 1.08

2.90 ± 1.42

 

ASA Physical Status Classification

  

0.865

 I

6(22.2)

7(24.1)

 

 II

21(77.8)

22(75.9)

 

Co-morbidities (n %)

   

 Hypertension

8(29.6)

9(31.0)

0.909

 Diabetes

2(7.4)

3(10.3)

0.535

 Hyperthyreosis

0

0

-

History of operation (n %)

2(7.4)

4(13.8)

0.734

Drinking status (n %)

10(37.0)

10(34.5)

0.842

Smoking status (n %)

9(33.3)

8(27.6)

0.430